Restenosis Clinical Trials

20 recruitingLast updated: June 17, 2026

There are 20 actively recruiting restenosis clinical trials across 16 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Beijing, Beijing Municipality, China, Lucerne, Canton of Lucerne, Switzerland, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Restenosis Trials at a Glance

20 actively recruiting trials for restenosis are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Beijing, Lucerne, and Boston. Lead sponsors running restenosis studies include Luzerner Kantonsspital, Peking Union Medical College Hospital, and Concept Medical Inc..

Browse restenosis trials by phase

Treatments under study

About Restenosis Clinical Trials

Looking for clinical trials for Restenosis? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Restenosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Restenosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Not Applicable

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Chronic Limb Threatening IschemiaPeripheral Arterial Disease(PAD)Restenosis+2 more
Hamilton Health Sciences Corporation772 enrolled2 locationsNCT06979284
Recruiting

Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

Coronary Arterial Disease (CAD)Bifurcation Coronary DiseaseRestenosis, Coronary
Olivier F. Bertrand1,500 enrolled1 locationNCT06972225
Recruiting
Not Applicable

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

Coronary angioplastyCoronary Artery DiseaseCoronary Artery Disease (CAD)+10 more
University Hospital, Clermont-Ferrand80 enrolled2 locationsNCT07316504
Recruiting

Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR

In-stent RestenosisPCIIntravascular Imaging Device
Nanjing First Hospital, Nanjing Medical University1,500 enrolled1 locationNCT07297641
Recruiting

Disease Characteristics of IR-CAD: a Case-control Study

Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital30 enrolled1 locationNCT06007248
Recruiting

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital39 enrolled1 locationNCT05860400
Recruiting

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital120 enrolled1 locationNCT06845410
Recruiting

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

Coronary Artery DiseaseArteritisIn-Stent Stenosis (Restenosis) of Coronary Artery Stent
China National Center for Cardiovascular Diseases1,000 enrolled1 locationNCT05437965
Recruiting
Phase 4

Anti-inflammatory Therapy for Recurrent In-stent Restenosis

In-stent Restenosis
Fu Wai Hospital, Beijing, China252 enrolled4 locationsNCT06090890
Recruiting
Phase 1Phase 2

Pilot Study of the α Prototype NIMBLE System: Feasibility, Safety, and Initial Performance in Non-Invasive Detection of Coronary In-Stent Restenosis

In-stent RestenosisStent FractureStent Complication
Nimble Diagnostics S.L.30 enrolled1 locationNCT06968858
Recruiting
Not Applicable

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Cardiovascular DiseasesCoronary Artery DiseaseIn-stent Restenosis
Concept Medical Inc.492 enrolled28 locationsNCT05908331
Recruiting
Not Applicable

Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Restenosis

Coronary Artery DiseaseStentStent Restenosis
San Luigi Gonzaga Hospital360 enrolled12 locationsNCT06779110
Recruiting
Not Applicable

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis

Coronary Stent Restenosis
Semmelweis University Heart and Vascular Center150 enrolled2 locationsNCT04862052
Recruiting

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Coronary RestenosisCoronary DiseaseCoronary Artery Disease+7 more
Luzerner Kantonsspital5,000 enrolled1 locationNCT06075602
Recruiting

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Coronary RestenosisCoronary DiseaseCoronary Artery Disease+7 more
Luzerner Kantonsspital2,000 enrolled1 locationNCT04988685
Recruiting
Not Applicable

The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial

Coronary DiseaseCoronary Artery DiseaseCoronary Artery Calcification+2 more
Luzerner Kantonsspital280 enrolled1 locationNCT05346068
Recruiting
Not Applicable

Carotid Endarterectomy vs. Repeated Carotid Angioplasty and Stenting for In-Stent Restenosis

In-Stent Carotid Artery Restenosis
University Hospital Ostrava40 enrolled1 locationNCT05390983
Recruiting

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study

Coronary Artery DiseaseIn-stent Restenosis
Seoul National University Hospital1,000 enrolled1 locationNCT06104007
Recruiting
Not Applicable

Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia

Stent ThrombosisStent RestenosisMesenteric Ischemia+7 more
Rigshospitalet, Denmark98 enrolled1 locationNCT05244629
Recruiting

A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions

Coronary RestenosisCoronary DiseaseMyocardial Ischemia+2 more
Abbott Vascular1,000 enrolled9 locationsACTRN12610000131055